Trial Profile
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamic and Efficacy of Taselisib in Patients with Advanced Solid Tumors or with HER2-positive Breast Cancer
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Taselisib (Primary)
- Indications Breast cancer; HER2 positive breast cancer; Solid tumours
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 10 Dec 2015 New trial record